GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.
A new study provides more evidence that glucagon-like peptide 1 receptor agonists used to treat diabetes and obesity could be repurposed for opioid use disorder and alcohol use disorder .
Until now, most studies on GLP-1 RAs and GIP agonists like tirzepatide to treat substance use disorders consisted of animal studies and small-scale clinical trials, investigators noted. Patients with OUD who were prescribed GLP-1 RAs had a 40% lower rate of opioid overdose than those without such prescriptions , the study team found.
“Future research should focus on prospective clinical trials to validate these findings, explore the underlying mechanisms, and determine the long-term efficacy and safety of GIP/GLP-1 RA medications in diverse populations,” Qeadan and colleagues concluded.
Opioids Overdose Drug Overdose Heroin Toxicity Heroin Overdose GLP-1 Receptor Agonists Glucagon-Like Peptide-1 Receptor Agonists Toxicology Toxicity Poisoning Toxins Weight Loss Obesity Obese Alcohol Use Receptors Healthcare And Medical Technology Health And Medical Tech Health And Med Tech Health And Medical Technology Healthcare Technology Medical Technology
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Weight-Loss Drugs Can Cause Bone LossAbby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she was working in medical writing, covering neurological news for healthcare professionals. She also published her nonfiction history book, The Marine Society of the City of New York 1770-2020, with Fort Schuyler press in 2020.
Read more »
Popular Weight Loss Drugs Spark Teen Eating Disorder ConcernsSome doctors fear use of weight loss drugs in teens will increase or exacerbate eating disorder cases, adding complexity to treatment.
Read more »
7 Mistakes People Make While Taking Weight Loss Drugs, According to ExpertsGLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught making these semaglutide slip-ups.
Read more »
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, WegovySima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Read more »
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugsWeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
Read more »
Stocks @ Night: Record Closures, Weight Loss Drugs & MoreCNBC's producers take a look at the market after the S&P 500 and Dow close at record highs on Monday, exploring key stories for tomorrow's trading session. From a potential deal with Nippon Steel to Congressional hearings on drug pricing, here's what investors need to know.
Read more »